A Phase 2 Randomised Clinical Trial Assessing the Tolerability of Two Different Ratios of Medicinal Cannabis in Patients With High Grade Gliomas

A Phase 2 Randomised Clinical Trial Assessing the Tolerability of Two Different Ratios of Medicinal Cannabis in Patients With High Grade Gliomas

BackgroundCannabis for cancer is very topical and, given the use of illicit cannabis preparations used in this vulnerable population, research investigating standardised, quality-assured medicinal cannabis is critical to inform clinicians and assist patient safety.MethodsA randomized trial involving...

Full description

Bibliographic Details
Main Authors: Janet Schloss, Judith Lacey, Justin Sinclair, Amie Steel, Michael Sughrue, David Sibbritt, Charles Teo
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
glioblastoma multiforme (GBM)
cannabis (marijuana)
medicinal marijuana
high-grade glioma (HGG)
tolerability
quality of life
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.649555/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.649555/full

Similar Items